Cytomegalovirus Reactivation in Non Immunocompromised Patients Undergoing Cardiac Surgery
NCT02527291 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2022-10-25
Summary
We hypothesized that the stress of cardiac surgery and cardiopulmonary bypass can cause reactivation of a latent CMV infection and that reactivation might be more prevalent in patients with complicated post-operative course. The study aims are:
* To study whether cardiac surgery is a trigger for latent CMV reactivation and to compare reactivation rate between sub groups of patient with complicated post-operative course and non complicated post operative course.
* To study the relationship between expression IL28 SNP rs12979860 and the risk of CMV replication in the non immunocompromised patient undergoing cardiac surgery.
Conditions
- Cardiac Surgery
Interventions
- OTHER
-
Blood test
Blood test for CMV PCR and IL28
Sponsors & Collaborators
-
Soroka University Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-11-30
- Primary Completion
- 2016-09-30
- Completion
- 2017-09-30
Countries
- Israel
Study Locations
More Related Trials
-
Prediction of Cytomegalovirus (CMV) Reactivation in Intensive Care Unit (ICU) by Immunological Study
NCT02843880 ·Status: TERMINATED
-
Cytomegalovirus (CMV) MicroRNA Expression in Vivo and Immune Evasion Correlates
NCT00677482 ·Status: COMPLETED
-
Clinical and Immunological Features of the CMV Infection Atypical Course in Immunocompetent Individuals
NCT04392297 ·Status: COMPLETED
-
Cytomegalovirus Spread and Reactivation in Blood Cells
NCT00006314 ·Status: COMPLETED
-
The Relationship Between CMV* Reactivation and Anti-cytokine Treatment in Critical COVID-19 Patients
NCT05419206 ·Status: COMPLETED
-
Cell Mediated Immunity With Risk of Cytomegalovirus (CMV) in Solid Organ Transplant Recipients
NCT01558037 ·Status: COMPLETED
-
A French Cohort of Transplant Recipients With CMV Infection : Risk Factors for Antiviral Resistance in the Prophylaxis Era.
NCT02067169 ·Status: COMPLETED
-
Impact of the Lack of CMV-Specific CD8+ T Cell Response in CMV-Seropositive Donors in CMV Reactivation After Hematopoietic Stem Cells Transplant in CMV-Seropositive Recipients
NCT03210090 ·Status: UNKNOWN
-
Cytomegalovirus Control in Critical Care
NCT01503918 ·Status: COMPLETED ·Phase: PHASE2
-
Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients
NCT00364052 ·Status: UNKNOWN
-
Impact of Cytomegalovirus (CMV) Replication Over Hepatitis C Recurrence in Liver Transplant Recipients
NCT01473849 ·Status: UNKNOWN
-
Immune Response to Cytomegalovirus
NCT00034437 ·Status: COMPLETED
-
Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction
NCT00001531 ·Status: COMPLETED
-
AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients
NCT04690933 ·Status: COMPLETED
-
Breakthrough CMV Lung Transplant -Multicentre
NCT04439916 ·Status: RECRUITING
-
A Study on Cytomegalovirus (CMV) Infection Outcomes Among Solid Organ Transplant (SOT) Participants in Europe and Canada
NCT05576805 ·Status: COMPLETED
-
Cell-mediated Immunity for Prevention of CMV Disease
NCT02538172 ·Status: COMPLETED ·Phase: NA
-
A Trial to Study How the Body Fights Off Cytomegalovirus (CMV) in Hematopoietic Transplant Recipients.
NCT00273143 ·Status: COMPLETED
-
Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients
NCT06494033 ·Status: RECRUITING
-
Natural History of Cytomegalovirus (CMV) Infection and Disease Among Renal Transplant Recipients
NCT01833416 ·Status: COMPLETED
-
Cytomegalovirus Reactivation in Cancer Patients Receiving Chemotherapy
NCT00366717 ·Status: COMPLETED
-
Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy
NCT00509691 ·Status: COMPLETED ·Phase: PHASE1
-
CMV-associated Immunomodulation in Renal Transplant Patients
NCT06976008 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Cytomegalovirus Infection in Critically Ill Patients and Patients Receiving Anticancer Therapy
NCT04280380 ·Status: UNKNOWN
-
Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation
NCT00170170 ·Status: COMPLETED